These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 26955714)
1. [Synergistic inhibitory effect of static magnetic field and antitumor drugs on Hepa1-6 cells]. Xu L; Guo W; Liu Y; Zhang X; Yu J; Wu W; Zhao T Sheng Wu Gong Cheng Xue Bao; 2015 Sep; 31(9):1363-74. PubMed ID: 26955714 [TBL] [Abstract][Full Text] [Related]
2. Effects of a moderate-intensity static magnetic field and adriamycin on K562 cells. Hao Q; Wenfang C; Xia A; Qiang W; Ying L; Kun Z; Runguang S Bioelectromagnetics; 2011 Apr; 32(3):191-9. PubMed ID: 21365663 [TBL] [Abstract][Full Text] [Related]
3. Static magnetic fields enhanced the potency of cisplatin on k562 cells. Chen WF; Qi H; Sun RG; Liu Y; Zhang K; Liu JQ Cancer Biother Radiopharm; 2010 Aug; 25(4):401-8. PubMed ID: 20707721 [TBL] [Abstract][Full Text] [Related]
4. An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes. Liu Y; Qi H; Sun RG; Chen WF Tumori; 2011; 97(3):386-92. PubMed ID: 21789021 [TBL] [Abstract][Full Text] [Related]
5. Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines. Zafari J; Rastegar-Pouyani N; Javani Jouni F; Najjar N; Azarshin SZ; Jafarzadeh E; Abdolmaleki P; Hoseini Shirazi F Sci Rep; 2024 Mar; 14(1):5792. PubMed ID: 38461218 [TBL] [Abstract][Full Text] [Related]
6. Combination of static magnetic field and cisplatin in order to reduce drug resistance in cancer cell lines. Jalali A; Zafari J; Jouni FJ; Abdolmaleki P; Shirazi FH; Khodayar MJ Int J Radiat Biol; 2019 Aug; 95(8):1194-1201. PubMed ID: 30822212 [No Abstract] [Full Text] [Related]
7. Simultaneous application of cisplatin and static magnetic field enhances oxidative stress in HeLa cell line. Kamalipooya S; Abdolmaleki P; Salemi Z; Javani Jouni F; Zafari J; Soleimani H In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):783-790. PubMed ID: 28936806 [TBL] [Abstract][Full Text] [Related]
8. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Foroodi F; Duivenvoorden WC; Singh G Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028 [TBL] [Abstract][Full Text] [Related]
9. Biologic effects of SMF and paclitaxel on K562 human leukemia cells. Sun RG; Chen WF; Qi H; Zhang K; Bu T; Liu Y; Wang SR Gen Physiol Biophys; 2012 Mar; 31(1):1-10. PubMed ID: 22447825 [TBL] [Abstract][Full Text] [Related]
10. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro. Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891 [TBL] [Abstract][Full Text] [Related]
11. Decreased P-glycoprotein is associated with the inhibitory effects of static magnetic fields and cisplatin on K562 cells. Zhang K; Chen W; Bu T; Qi H; Sun R; He X Bioelectromagnetics; 2014 Sep; 35(6):437-43. PubMed ID: 25099308 [TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471 [TBL] [Abstract][Full Text] [Related]
13. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells. Di X; Gennings C; Bear HD; Graham LJ; Sheth CM; White KL; Gewirtz DA Breast Cancer Res Treat; 2010 Nov; 124(2):349-60. PubMed ID: 20155316 [TBL] [Abstract][Full Text] [Related]
14. [Study on sensitivity to adriamycin of down-regulated cells expressed hOGG1 gene which target to oxidative DNA damage and repair]. Wu M; Zhang ZZ; Ran Y; Zhang H; Liu F Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):9-13. PubMed ID: 17294717 [TBL] [Abstract][Full Text] [Related]
15. [Influence of mifepristone on DNA repair genes and cisplatin sensitivity in human ovarian cancer drug-resistance cells]. Liu GY; Qu QX; Mi RR; Qi J Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):132-5. PubMed ID: 18683754 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells. Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458 [TBL] [Abstract][Full Text] [Related]
17. Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines. Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D Int J Oncol; 2013 Apr; 42(4):1263-70. PubMed ID: 23403907 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines. Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946 [TBL] [Abstract][Full Text] [Related]
19. Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol. Luo Y; Ji X; Liu J; Li Z; Wang W; Chen W; Wang J; Liu Q; Zhang X Bioelectrochemistry; 2016 Jun; 109():31-40. PubMed ID: 26775206 [TBL] [Abstract][Full Text] [Related]
20. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS]. Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]